Ultragenyx Pharmaceutical (RARE) Change in Intangibles (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Change in Intangibles of $5.0 million for Q1 2026, down 66.67% year-over-year from $15.0 million in Q1 2025, and down 66.67% quarter-over-quarter from $15.0 million in Q1 2025.
Ultragenyx Pharmaceutical (RARE) Change in Intangibles (2018 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has 7 years of Change in Intangibles data on file, last reported at $5.0 million in Q1 2026.
- Change in Intangibles for Q1 2026 came in at $5.0 million, down 66.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 72.22% YoY), and the FY2025 annual result was $15.0 million, up 15.38% from the prior year.
- Change in Intangibles eased to $5.0 million in Q1 2026 per RARE's latest filing, from $15.0 million in the prior quarter.
- Over five years, Change in Intangibles peaked at $30.0 million in Q1 2022 and troughed at $500000.0 in Q4 2023.
- A 5-year average of $8.2 million and a median of $3.8 million in 2023 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2025 and 2026: Change in Intangibles soared 50.0% in 2025, then sank 66.67% in 2026.
- A 5-year view of Change in Intangibles shows it stood at $30.0 million in 2022, then sank by 98.33% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then surged by 2900.0% to $15.0 million in 2025, then sank by 66.67% to $5.0 million in 2026.
- Business Quant data shows RARE's Change in Intangibles at $5.0 million in Q1 2026, $15.0 million in Q1 2025, and $500000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Jun 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Jun 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.50 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Dec 31, 2020 | -2.28 Mn |
| Dec 31, 2020 | -2.28 Mn |
| Jun 30, 2018 | 80.60 Mn |
| Jun 30, 2018 | 80.60 Mn |